Literature DB >> 7988424

Fibroblast growth factor receptor type 1 expression during rat testicular development and its regulation in cultured Sertoli cells.

B Le Magueresse-Battistoni1, J Wolff, A M Morera, M Benahmed.   

Abstract

In the present study, we examined the ontogeny of the type 1 receptor for basic fibroblast growth factor (FGFR-1) in whole rat testis, its cellular localization, and its in vitro regulation in 20-day-old rat Sertoli cells. Gene expression of FGFR-1 was developmentally regulated; expression was higher in prepubertal testes and decreased with sexual maturity. The transcript was found to be expressed in Leydig-enriched fractions, peritubular cells, Sertoli cells, and, to a lesser extent, germ cells. FSH as well as (Bu)2cAMP enhanced FGFR-1 messenger RNA (mRNA) levels in cultured Sertoli cells, suggesting an involvement of the protein kinase-A pathway. Addition of basic FGF (bFGF), tumor necrosis factor-alpha (TNF alpha), or interleukin-1 alpha resulted in a dose- and time-related increase in FGFR-1 mRNA levels. The effect of bFGF was specific, because it was neutralized by cotreatment with an anti-bFGF. We tested medium conditioned by germ cells and found a stimulation of the Sertoli cell FGFR-1 mRNA levels, which was abolished by immunodepletion of the conditioned medium with anti-TNF alpha antibodies. It is suggested that in Sertoli cells, bFGF action, when mediated by FGFR-1, is under a complex hormonal (FSH) and paracrine and/or autocrine control exerted at least by bFGF, TNF alpha, and interleukin-1 alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988424     DOI: 10.1210/endo.135.6.7988424

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  Hormonal control of Sertoli cell metabolism regulates spermatogenesis.

Authors:  Marco G Alves; Luís Rato; Rui A Carvalho; Paula I Moreira; Sílvia Socorro; Pedro F Oliveira
Journal:  Cell Mol Life Sci       Date:  2012-07-20       Impact factor: 9.261

2.  Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations.

Authors:  Shuying Li; Yaling Zhao; Min Nie; Wanlu Ma; Xi Wang; Wen Ji; Yufan Yang; Ming Hao; Bingqing Yu; Yinjie Gao; Jiangfeng Mao; Xueyan Wu
Journal:  Int J Endocrinol       Date:  2020-11-28       Impact factor: 3.257

3.  The effects of an in utero exposure to 2,3,7,8-tetrachloro-dibenzo-p-dioxin on male reproductive function: identification of Ccl5 as a potential marker.

Authors:  D Rebourcet; F Odet; A Vérot; E Combe; E Meugnier; S Pesenti; P Leduque; H Déchaud; S Magre; B Le Magueresse-Battistoni
Journal:  Int J Androl       Date:  2009-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.